Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo
Official title: A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo
Status: Opening soon
Description:
This study is a multicenter, open-label, non-randomized study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with Non-Segmental Vitiligo
Phases: Phase 1, Phase 2.
What is being studied: drug — VC005 tablets.
Who can take part: ages 12 Years to 18 Years, 10 participants planned.
Enrollment status: Opening soon. The study started 25 September 2026 and is expected to finish 30 May 2027.
Contact: xiaojuan Lai.
Source: ClinicalTrials.gov, NCT07828639 (https://clinicaltrials.gov/study/NCT07828639).
Start date: September 25, 2026
Completion date: May 30, 2027
Organizer: Jiangsu vcare pharmaceutical technology co., LTD
Contact: xiaojuan Lai
Tel.: 15358160458
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
- Is it Bitiligo? Vitaligo? Veteligo?
There are so many different ways that people try and spell or even pronounce Vitiligo. Here are some common mis-spellings: bitiligo, vitigo, vitaligo, vitilago, vitiglio, vitag...
- How Vitiligo Changes with Age?
Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.